 |
Stacey B. Daughters, Ph.D. Research Assistant Professor Director, Addictions Division Center for Addictions, Personality, and Emotion Research Department of Psychology University of Maryland College Park, MD 20742 Office: 2103D, Cole Field House Phone: 301-405-5760 Fax: 301-405-3223 E-mail: sdaughters@psyc.umd.edu |
| Bio |
BACKGROUND INFORMATION
Dr. Daughters received her Ph.D. in Clinical Psychology from the University of Maryland in 2005 following completion of her clinical internship at the Brown University School of Medicine. She is currently a Research Assistant Professor in the Department of Psychology and the Director of the Addictions Division of the Center for Addictions, Personality, and Emotion Research (CAPER). She was recently awarded a 2006 Early Career Award from the College of Problems on Drug Dependence (CPDD) and a fellowship from the Center for AIDS Prevention Studies (CAPS) at the University of California, San Francisco to serve as a Visiting Professor for three consecutive summers to receive specialized training in conducting HIV prevention research. She has co-authored over 25 peer-reviewed articles and book chapters and is the PI on a NIDA grant (R21 DA022741) investigating the relationship between distress tolerance and adolescent substance use and associated HIV risk behavior. She is also a Co-Investigator on two currently funded grants, one examining risky sexual behavior among inner-city illicit drug users (R01 19495; PI: Lejuez), and another testing the effectiveness of a distress tolerance treatment for patients with low distress tolerance (R36 21972; PI: Bornovalova).
RESEARCH INTERESTS
Dr. Daughters research interests focus on integrating basic
research and clinical practice in the understanding of addictive disorders, with
a specific focus on identifying individual risk factors for treatment failure
and developing interventions to target those risk factors. Her primary research
interests include (1) examining distress tolerance as a predictor of early
treatment dropout and relapse among illicit drug users, (2) the development of
an integrated treatment to improve medication adherence and decrease depressive
symptoms and sexual risk taking behavior among HIV positive inner-city substance
users, (3) investigating the role of distress tolerance as predictor of the
development and persistence of substance use and associated risk behavior among
adolescents, and (4)
the development
of a distress tolerance assessment paradigm for use in functional magnetic
resonance imaging (fMRI) to determine the neurobiological correlates of distress
tolerance.
Dr. Daughters mentors graduate students in the Clinical Psychology Program in
conjunction with Dr. Lejuez through the Center for Addictions, Emotion, and
Personality Research (CAPER). Interested students should be sure to mention both
Dr. Daughters and Dr. Lejuez in their application for admission.
SELECTED PUBLICATIONS
1. Daughters, S.B., Braun, A.R., Sargeant, M.N., Reynolds, E.R., Hopko, D., Blanco, C., & Lejuez, C.W. (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The Life Enhancement Treatment for Substance Use (LETS ACT!). The Journal of Clinical Psychiatry, 69, 122-129.
Daughters, S.B., Stipelman, B.A., Sargeant, M.N., Schuster, R., Bornovalova, M.A., & Lejuez, C.W. (2008). The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout. Journal of Substance Abuse Treatment, 34, 157-164..
Daughters, S.B., Bornovalova, M.B., Correia, C., & Lejuez, C.W. (2007). Psychoactive Substance Use Disorders: Drugs. In Turner, Samuel M (Ed), Hersen, Michel (Ed), Adult psychopathology and diagnosis (5th ed.). New York, NY, US: John Wiley & Sons, Inc.
Kahler, C.W., Daughters, S.B., Leventhal, A.M., Gwaltney, C.J., & Palfai, T.P. (2007). Implicit associations between smoking and social consequences among smokers in cessation treatment. Behaviour Research and Therapy, 45, 2066-2077.
Daughters, S.B., Lejuez, C.W., Bornovalova, M.A., Kahler, C., Strong, D., & Brown, R. (2005). Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. Journal of Abnormal Psychology, 114, 729-734.
Daughters, S. D., Lejuez, C. W., Lesieur, H. R., Strong, D. R., & Zvolensky, M. J. (2003). Towards a better understanding of gambling treatment failure: implications of translational research. Clinical Psychology Review, 23(4), 573-586.
GRANTS
Distress Tolerance and Adolescent
Substance Use
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R21 DA022741
Period: 9/1/07 - 8/30/09
Total Project Period: 2 Years
Overall Goal: To examine the relationship between distress tolerance and adolescent substance use.
Distress Tolerance and Drug Treatment
Drop-out
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R03 DA01387
Period: 9/1/04 - 6/30/06 (no cost extension through 6/30/07)
Overall Goal: To examine distress tolerance as a predictor of treatment
drop-out
among inner-city substance users in residential treatment.
Drug Choice, Impulsivity, and Risky Sexual Behavior
Principal Investigator: Carl W. Lejuez, Ph.D.
Co-Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R01 DA19405
Period: 6/01/06 - 5/31/08
Overall Goal: To examine sexual risk taking as a function of drug choice,
exploring a multidimensional assessment of impulsivity as a potential mediator
of this relationship.
Distress Tolerance Treatment for
Inner-City Drug Users
Principal
Investigator: Marina A. Bornovalova, M.A.
Co-Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute on Drug Abuse
Type and Number: R36 DA021820
Period: 10/01/06 - 9/30/08
Overall Goal: To develop and test the effectiveness of a distress
tolerance-focused treatment
for the specific purpose of preventing treatment
drop-out in a residential substance use treatment setting.
Under Review
Distress Tolerance and Drug Treatment Failure
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA021750
Total Project Period: 4 Years
Overall Goal: To examine distress
tolerance as a predictor of relapse to substance use
following residential
treatment among inner-city crack/cocaine and heroin users.
Behavioral Depression Treatment
for Minority HIV-infected Substance Users
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA022974
Total Project Period: 5 Years
Goal: To develop and test the
effectiveness of an integrated treatment to improve
medication adherence and
decrease depressive symptoms and sexual risk taking
behavior among HIV positive
inner-city substance users.
Development and Pilot Test of a Functional MRI Distress Tolerance Task
Principal Investigator: Stacey B. Daughters, Ph.D.
Agency, Type, and Number: National Institute of Drug Abuse R03 DA025154
Total Project Period: 1 Year
Total Direct Costs: $150,000
Overall Goal: To develop and validate a distress tolerance task for use in fMRI.